IGF-1 DES is a truncated analogue of IGF-1 where the first three amino acids are removed, resulting in a compound that binds more rapidly and strongly to IGF receptors in localized tissues (based on experimental studies).
In research environments, it is primarily investigated for:
- Cellular proliferation and differentiation
- Muscle and connective tissue regeneration models
- Growth factor signaling pathways (PI3K/Akt and related mechanisms)
- Tissue repair and recovery studies in vitro and in animal models
Unlike full-length IGF-1, IGF-1 DES is considered to have a shorter systemic half-life and more localized activity in experimental contexts.



Reviews
There are no reviews yet.